Imagin Medical Inc.

    Imagin Medical Inc.

    CCSE:IME
    - -
    CAD
    - -
    - -
    Imagin Medical Inc.
    CSE:IME
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2007
    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -17.08
    -55.5
    -35.77
    -0.41
    -8.78
    -9.9
    -2.54
    -10.36
    -1.3
    -1.68
    -0.63
    -1.48
    -0.64
    -0.53
    -1.27
    -0.25
    -0.31
    Basic EPS, GAAP
    -40.69
    -23.68
    -4.58
    -6.95
    -10.57
    -6.99
    -3.3
    -3.38
    -0.55
    -1.15
    -0.27
    -0.86
    -0.59
    -0.5
    -0.45
    -0.34
    -0.16
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    97.9
    53.44
    18.1
    18.16
    22.86
    13.77
    11.51
    1.17
    - -
    0.06
    -0.2
    0.9
    0.3
    -0.04
    -1.25
    -1.23
    -1.1
    Book Value per Share
    97.9
    53.44
    18.1
    18.16
    22.86
    13.77
    11.51
    1.17
    -0.07
    -0.01
    -0.26
    0.88
    0.28
    -0.05
    -1.26
    -1.34
    -1.19
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    5
    7
    8
    9
    10
    11
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -2
    -8
    -6
    - -
    -2
    -2
    - -
    -2
    - -
    -2
    -2
    -8
    -4
    -4
    -11
    -2
    -3
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    1
    1
    1
    3
    2
    1
    - -
    - -
    - -
    -1
    6
    2
    - -
    -12
    -15
    -13
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    13
    8
    3
    3
    4
    3
    2
    - -
    - -
    - -
    -1
    6
    2
    - -
    -12
    -13
    -12
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1,269.37
    Return on Capital (%)
    -19.55
    -76.1
    -99.9
    -2.25
    -42.5
    -54.14
    -20.12
    -163.74
    -51.36
    -3,594.49
    - -
    - -
    -110
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Dec'23
    Mar'23
    Jun'23
    ST Debt
    13
    14
    11
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    11
    11
    11
    Market Capitalization
    3
    3
    2

    Working Capital

    CAD

    •

    in mil. unless spec.
    Dec'23
    Mar'23
    Jun'23
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    15
    15
    13
    Payables & Accruals
    2
    2
    2
    ST Debt
    13
    14
    11
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    78,681.44%
    390.44%
    15.55%
    Free Cash Flow
    652.38%
    112.67%
    -16.9%
    Net Income, GAAP
    433.98%
    90.82%
    -78.28%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    -0.06
    -0.26
    -0.05
    - -
    -1.27
    2022
    -0.14
    -0.11
    0.46
    - -
    -0.25
    2023
    - -
    -0.08
    0.2
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business